Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Liver Cirrhosis
100%
Mechanism-based
100%
Targeted Therapy
100%
Primary Biliary Cholangitis
100%
Pathogenic Mechanism
33%
Ursodeoxycholic Acid
33%
Cirrhosis
33%
Disease Progression
16%
Pathophysiology
16%
Disease Stage
16%
Progressive Fibrosis
16%
Liver Failure
16%
Liver Fibrosis
16%
Clinical Trials
16%
Therapeutic Potential
16%
Cellular Mechanisms
16%
Therapeutic Effect
16%
Potential Therapeutics
16%
Second-line Treatment
16%
Cholestasis
16%
Immune Dysregulation
16%
Immune Pathogenesis
16%
Immunological Mechanisms
16%
Fibrosis
16%
Cholangitis
16%
Terminal Stage
16%
Biliary Injury
16%
Antifibrotic
16%
Bile Metabolism
16%
Immune-mediated Liver Injury
16%
Current Mechanism
16%
Potential Therapeutic Strategies
16%
Obeticholic Acid
16%
Suppurative
16%
Anti-inflammatory Therapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
100%
Primary Biliary Cirrhosis
100%
Diseases
33%
Fibrosis
33%
Ursodeoxycholic Acid
33%
Clinical Trial
16%
Anti-Inflammatory Drug
16%
Liver Failure
16%
Liver Disease
16%
Pathophysiology
16%
Disease Exacerbation
16%
Therapeutic Effect
16%
Immune Dysregulation
16%
Cholestasis
16%
Liver Fibrosis
16%
Obeticholic Acid
16%
Cholangitis
16%